According to GlobalData, Ansell’s manufacturing plant in Tamil Nadu would increase surgical glove sales in India.

0
495
WhatsApp D. Pharma Group Join Now
Telegram D. Pharma Group Join Now
Telegram Group Latest Pharma Jobs Join Now
Telegram B. Pharma Group Join Now
Telegram Medicine Update Group Join Now
WhatsApp B. Pharma/ GPAT Channel Join Now

According to GlobalData, a leading data and analytics company, Ansell Limited, an Australian manufacturer of personal protective equipment, is expected to propel the Indian surgical glove market, advance sustainable manufacturing, and support the “Made in India” initiative with its new manufacturing facility in Tamil Nadu. Ansell recently celebrated the $20 million first investment in the first phase of the commissioning of its packaging and irradiation activities at its new production site in Kovai, Tamil Nadu.

The personal protective equipment market in India is predicted to expand at a compound annual growth rate of roughly 5% between 2023 and 2030, according to GlobalData’s report, “Personal Protective Equipment Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030.” “The use of personal protective equipment such as gloves, gowns, masks, and face shields will be in high demand in the future as the number of surgeries and hospital visits increases exponentially due to the rising chronic diseases and the ageing population,” said Jyoti Sharma, a medical devices analyst at GlobalData.

The facility’s goal is to produce economical, high-quality gloves and contribute to the creation of environmentally friendly medical items. It has zero liquid emissions and was built with low-carbon, eco-friendly, non-toxic, and reusable materials. Ansell has already spent US$ 80 million establishing world-class facilities, and it will continue to do so in order to supply the global demand for premium medical gloves. “Such long-term agreements will not only make it possible to meet domestic needs but will also expand India’s export market,” says Sharma in his conclusion. This will support the “Made in India” movement and assist India in becoming a desirable manufacturing hub.

While production is primarily focused on producing surgical and life sciences products, Ansell stated in December 2022 that this facility is designed with significant future expansion capability to accommodate a wide range of Ansell products, such as its examination glove line, and supporting our differentiated growth strategy in the coming years. A 43,000 square metre manufacturing plant, a compounding facility, a dipping hall, a post-processing building, a warehouse, a packaging facility, an administrative block, a canteen, biomass hot water generators and an industrial gamma irradiator will all be part of Ansell Kovai when it is finished in 2024.

The company claims that when this facility is finished, it will establish a new standard for sustainable production at Ansell. When the facility is fully operational, it will be the first in the glove industry to operate with zero liquid discharge, which means that all wastewater is completely recycled and used again in manufacturing. Low-carbon, low-impact, non-toxic, and recycled materials are used in the Kovai plant’s construction. Ansell has committed to switching our plants over to renewable energy sources from fossil fuel-based ones. In order to come closer to our objective of using only renewable energy at this location, the new plant design minimises water and energy use and maximises renewable energy sources, such as solar photovoltaic panels and biomass for thermal energy that is sourced sustainably.

Download Pharmacy India Mobile App from Play store for the preparation of GPAT, NIPER, Pharmacist, DI and other Pharma Exams.


kn

LEAVE A REPLY

Please enter your comment!
Please enter your name here